🇺🇸 Gonal-f® RFF in United States

FDA authorised Gonal-f® RFF on 25 March 2004

Marketing authorisation

FDA — authorised 25 March 2004

  • Application: BLA021765
  • Marketing authorisation holder: EMD SERONO
  • Local brand name: GONAL-F RFF
  • Indication: INJECTABLE — SUBCUTANEOUS
  • Status: approved

Read official source →

Other Reproductive Medicine / Fertility approved in United States

Frequently asked questions

Is Gonal-f® RFF approved in United States?

Yes. FDA authorised it on 25 March 2004.

Who is the marketing authorisation holder for Gonal-f® RFF in United States?

EMD SERONO holds the US marketing authorisation.